Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments

This investigation aimed to assess the effect of N-acetylcysteine (NAC) as an adjuvant treatment to alleviate visceral leishmaniasis (VL). The present work includes both blinded randomized clinical intervention and experimental in vitro studies. The clinical trial included 60 patients with VL random...

Descripción completa

Detalles Bibliográficos
Autores principales: Magalhães, Lucas Sousa, Melo, Enaldo Vieira, Damascena, Nayra Prata, Albuquerque, Adriana Cardoso Batista, Santos, Camilla Natália Oliveira, Rebouças, Mônica Cardozo, Bezerra, Mariana de Oliveira, Louzada da Silva, Ricardo, de Oliveira, Fabricia Alvisi, Santos, Priscila Lima, da Silva, João Santana, Lipscomb, Michael Wheeler, da Silva, Ângela Maria, de Jesus, Amélia Ribeiro, de Almeida, Roque Pacheco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730326/
https://www.ncbi.nlm.nih.gov/pubmed/36506010
http://dx.doi.org/10.3389/fcimb.2022.1045668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730326/
https://www.ncbi.nlm.nih.gov/pubmed/36506010
http://dx.doi.org/10.3389/fcimb.2022.1045668

Ejemplares similares